查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1362927

口干症治疗药物市场规模、份额、趋势分析报告：按类型、按产品、地区和细分市场预测，2023-2030

Xerostomia Therapeutics Market Size, Share & Trends Analysis Report By Type (OTC, Prescription), By Product (Salivary Stimulants, Salivary Substitutes, Dentifrices), By Region, And Segment Forecasts, 2023 - 2030
出版日期: | 出版商: Grand View Research | 英文 120 Pages | 商品交期: 2-10个工作天内

价格

口干症治疗市场的成长与趋势：

Grand View Research, Inc.最新报告显示，2023年至2030年，全球口干症治疗市场规模预计将以3.8%的年复合成长率成长，2030年达到27亿美元。

口干症产品优惠报销政策的增加和对相关疾病的认识不断提高是推动市场成长的主要要素。

此外，口干症和干燥症候群、糖尿病、高血压和帕金森氏症等相关疾病的患病，对整个市场产生了积极影响。据高露洁棕榄称，美国有 2500 万人患有口干症。据美国干燥综合症基金会称，大约有 400 万美国人患有干燥症候群，这是一种自体免疫疾病。

提高对口干症及相关疾病意识的措施预计将推动成长。例如，美国干燥症候群基金会在美国和加拿大开展提高意识计划，以帮助患有症候群的患者。 2012年，基金会推出了5年突破目标，旨在2017年将该症候群的诊断时间缩短至2.5年以内。

此外，领先公司正专注于收购新兴企业并实施计划，以提高对口干症状的认识。例如，Church &Dwight Co., Inc. 旗下品牌 Orajel 与数位行销机构 iCrossing 合作，发起了一项活动，教育家长了解口腔清洁用品的重要性。

口干症治疗药物市场报告亮点

  • 预计到2022年，口干症药物的全球市场规模将达到20亿美元，预计2023年至2030年年复合成长率为3.8%。
  • 由于可用性、可负担性和高效率要素，OTC 领域在市场上占据主导地位。
  • 预计牙科用细分市场在预测期内将以最快的年复合成长率成长。
  • 由于导致口干的疾病患病不断上升以及意识提升的倡议不断增加等要素，北美在 2022 年占据了最大份额。
  • 由于人们对该疾病的认识不断提高以及医疗保健支出不断增加，预计亚太地区在未来年度将出现良好的增长。
  • 葛兰素史克、Church & Dwight 和高露洁棕榄等主要企业主导全球口干症药物市场。

目录

第1章调查方法和范围

第2章执行摘要

第3章.口干症治疗药物市场的变数、趋势与范围

  • 市场体系预测
    • 母市场预测
    • 相关/附随市场预测
  • 普及和成长预测图
  • 市场动态
    • 市场促进因素分析
    • 市场抑制因素分析
  • 口干症治疗药物市场分析工具
    • 产业分析-波特五力分析
    • PESTEL分析

第4章口干症治疗药物：种类估算及趋势分析

  • 口干症治疗药物市场：重点
  • 口干症治疗药物市场：2022 年和 2030 年趋势和市场占有率分析
  • 店面销售(OTC)
    • 在商店
  • 处方笺
    • 2018年至2030年处方笺市场估计与预测

第5章口干症治疗药物：产品估算与趋势分析

  • 口干症治疗药物市场：重点
  • 口干症治疗药物市场：2022 年和 2030 年趋势和市场占有率分析
  • 唾液分泌兴奋剂
  • 唾液替代
  • 牙膏

第6章口干症治疗药物市场：区域估计与趋势分析

  • 区域预测
  • 口干症治疗药物系统市场：按地区分類的主要市场点
  • 北美洲
    • 2018-2030 年市场估计与预测
    • 美国
    • 加拿大
  • 欧洲
    • 英国
    • 德国
    • 法国
    • 义大利
    • 西班牙
    • 瑞典
    • 挪威
    • 丹麦
  • 亚太地区
    • 中国
    • 日本
    • 印度
    • 澳洲
    • 泰国
    • 韩国
  • 拉丁美洲
    • 巴西
    • 墨西哥
    • 阿根廷
  • 中东/非洲
    • 沙乌地阿拉伯
    • 南非
    • 阿拉伯聯合大公国
    • 科威特

第7章竞争形势

  • 主要市场参与企业的最新趋势和影响分析
  • 市场参与企业分类
    • Acacia Pharma
    • Parnell Pharmaceuticals, Inc.
    • Pfizer, Inc.
    • GlaxoSmithKline plc
    • Church & Dwight Co., Inc.
    • Lupin
    • Sun Pharmaceutical Industries, Ltd.
    • Hikma Pharmaceuticals PLC
    • Pendopharm
    • OraCoat
Product Code: GVR-1-68038-628-8

Xerostomia Therapeutics Market Growth & Trends:

The global xerostomia therapeutics market size is expected to reach USD 2.70 billion by 2030, expanding at a CAGR of 3.8% from 2023 to 2030, according to a new report by Grand View Research, Inc.. Increase in favorable reimbursement policies for xerostomia products and growing awareness about associated diseases are the major factors contributing toward market growth.

In addition, increasing prevalence of xerostomia and associated diseases such as Sjogren's syndrome, diabetes, hypertension, and Parkinson's disease has a positive impact on the overall market. According to Colgate-Palmolive Company, 25 million people in the U.S. experience dry mouth. According to Sjogren Syndrome Foundation of America, around 4 million Americans are suffering from Sjogren's syndrome, an autoimmune disorder.

Growing initiatives for raising awareness about xerostomia and associated diseases are expected to drive growth. For instance, Sjogren Syndrome Foundation of America conducts awareness programs and supports patients suffering from the syndrome in the U.S. and Canada. In 2012, the foundation launched the "5-Year Breakthrough Goal" with an aim to reduce the time required to diagnose the condition to less than 2.5 years by 2017.

Furthermore, major players focus on acquiring emerging companies and conduct programs to raise awareness about dry mouth condition. For instance, Orajel, a brand of Church & Dwight Co., Inc. initiated a campaign with the help of iCrossing, a digital marketing agency to educate parents about the importance of oral care.

Xerostomia Therapeutics Market Report Highlights:

  • The global xerostomia therapeutics market size was estimated at USD 2.0 billion in 2022 and is expected to grow with CAGR of 3.8% from 2023 to 2030
  • The OTC segment dominated the market due to factors such as ease in availability, affordability, and higher efficiency
  • The dentifrices segment is expected to grow at the fastest CAGR over the forecast period.
  • North America held the largest share in 2022 owing to factors such as increasing prevalence of diseases resulting in dry mouth and growing initiatives for raising awareness about xerostomia
  • The Asia Pacific region is anticipated to witness lucrative growth over the next decade due to increasing awareness of the disease and growing healthcare expenditure
  • Some of the key players such as GlaxoSmithKline plc; Church & Dwight Co., Inc.; and Colgate-Palmolive Company dominated the global xerostomia therapeutics market

Table of Contents

Chapter 1. Methodology and Scope

  • 1.1. Market Segmentation & Scope
    • 1.1.1. Type
    • 1.1.2. Product
    • 1.1.3. Regional scope
    • 1.1.4. Estimates and forecast timeline
  • 1.2. Research Methodology
  • 1.3. Information Procurement
    • 1.3.1. Purchased database
    • 1.3.2. GVR's internal database
    • 1.3.3. Secondary sources
    • 1.3.4. Primary research
    • 1.3.5. Details of primary research
  • 1.4. Information or Data Analysis
    • 1.4.1. Data analysis models
  • 1.5. Market Formulation & Validation
  • 1.6. Model Details
  • 1.7. List of Secondary Sources
  • 1.8. List of Primary Sources
  • 1.9. Objectives

Chapter 2. Executive Summary

  • 2.1. Market Outlook
  • 2.2. Segment Outlook
    • 2.2.1. Product outlook
    • 2.2.2. Regional outlook
  • 2.3. Competitive Insights

Chapter 3. Xerostomia Therapeutics Market Variables, Trends & Scope

  • 3.1. Market Lineage Outlook
    • 3.1.1. Parent market outlook
    • 3.1.2. Related/ancillary market outlook
  • 3.2. Penetration & Growth Prospect Mapping
  • 3.3. Market Dynamics
    • 3.3.1. Market driver analysis
    • 3.3.2. Market restraint analysis
  • 3.4. Xerostomia Therapeutics Market Analysis Tools
    • 3.4.1. Industry analysis - Porter's
      • 3.4.1.1. Supplier power
      • 3.4.1.2. Buyer power
      • 3.4.1.3. Substitution threat
      • 3.4.1.4. Threat of new entrant
      • 3.4.1.5. Competitive rivalry
    • 3.4.2. PESTEL analysis
      • 3.4.2.1. Political landscape
      • 3.4.2.2. Technological landscape
      • 3.4.2.3. Economic landscape

Chapter 4. Xerostomia Therapeutics: Type Estimates & Trend Analysis

  • 4.1. Xerostomia Therapeutics Market: Key Takeaways
  • 4.2. Xerostomia Therapeutics Market: Movement & Market Share Analysis, 2022 & 2030
  • 4.3. Over-the-counter (OTC)
    • 4.3.1. Over-the-counter (OTC) market estimates and forecast 2018 to 2030 (USD million)
  • 4.4. Prescription
    • 4.4.1. Prescription market estimates and forecast 2018 to 2030 (USD million)

Chapter 5. Xerostomia Therapeutics: Product Estimates & Trend Analysis

  • 5.1. Xerostomia Therapeutics Market: Key Takeaways
  • 5.2. Xerostomia Therapeutics Market: Movement & Market Share Analysis, 2022 & 2030
  • 5.3. Salivary Stimulants
    • 5.3.1. Salivary stimulants market estimates and forecast 2018 to 2030 (USD million)
  • 5.4. Salivary Substitutes
    • 5.4.1. Salivary substitutes market estimates and forecast 2018 to 2030 (USD Million)
  • 5.5. Dentifrices
    • 5.5.1. Dentifrices market estimates and forecast 2018 to 2030 (USD million)

Chapter 6. Xerostomia Therapeutics Market: Regional Estimates & Trend Analysis

  • 6.1. Regional Outlook
  • 6.2. Xerostomia Therapeutics System Market by Region: Key Marketplace Takeaway
  • 6.3. North America
    • 6.3.1. Market estimates and forecast, 2018 - 2030 (Revenue, USD Million)
    • 6.3.2. U.S.
      • 6.3.2.1. Market estimates and forecast, 2018 - 2030 (Revenue, USD Million)
    • 6.3.3. Canada
      • 6.3.3.1. Market estimates and forecast, 2018 - 2030 (Revenue, USD Million)
  • 6.4. Europe
    • 6.4.1. UK
      • 6.4.1.1. Market estimates and forecast, 2018 - 2030 (Revenue, USD Million)
    • 6.4.2. Germany
      • 6.4.2.1. Market estimates and forecast, 2018 - 2030 (Revenue, USD Million)
    • 6.4.3. France
      • 6.4.3.1. Market estimates and forecast, 2018 - 2030 (Revenue, USD Million)
    • 6.4.4. Italy
      • 6.4.4.1. Market estimates and forecast, 2018 - 2030 (Revenue, USD Million)
    • 6.4.5. Spain
      • 6.4.5.1. Market estimates and forecast, 2018 - 2030 (Revenue, USD Million)
    • 6.4.6. Sweden
      • 6.4.6.1. Market estimates and forecast, 2018 - 2030 (Revenue, USD Million)
    • 6.4.7. Norway
      • 6.4.7.1. Market estimates and forecast, 2018 - 2030 (Revenue, USD Million)
    • 6.4.8. Denmark
      • 6.4.8.1. Market estimates and forecast, 2018 - 2030 (Revenue, USD Million)
  • 6.5. Asia Pacific
    • 6.5.1. China
      • 6.5.1.1. Market estimates and forecast, 2018 - 2030 (Revenue, USD Million)
    • 6.5.2. Japan
      • 6.5.2.1. Market estimates and forecast, 2018 - 2030 (Volume, Thousand)
    • 6.5.3. India
      • 6.5.3.1. Market estimates and forecast, 2018 - 2030 (Revenue, USD Million)
    • 6.5.4. Australia
      • 6.5.4.1. Market estimates and forecast, 2018 - 2030 (Revenue, USD Million)
    • 6.5.5. Thailand
      • 6.5.5.1. Market estimates and forecast, 2018 - 2030 (Revenue, USD Million)
    • 6.5.6. South Korea
      • 6.5.6.1. Market estimates and forecast, 2018 - 2030 (Revenue, USD Million)
  • 6.6. Latin America
    • 6.6.1. Brazil
      • 6.6.1.1. Market estimates and forecast, 2018 - 2030 (Revenue, USD Million)
    • 6.6.2. Mexico
      • 6.6.2.1. Market estimates and forecast, 2018 - 2030 (Revenue, USD Million)
    • 6.6.3. Argentina
      • 6.6.3.1. Market estimates and forecast, 2018 - 2030 (Revenue, USD Million)
  • 6.7. MEA
    • 6.7.1. Saudi Arabia
      • 6.7.1.1. Market estimates and forecast, 2018 - 2030 (Revenue, USD Million)
    • 6.7.2. South Africa
      • 6.7.2.1. Market estimates and forecast, 2018 - 2030 (Revenue, USD Million)
    • 6.7.3. UAE
      • 6.7.3.1. Market estimates and forecast, 2018 - 2030 (Revenue, USD Million)
    • 6.7.4. Kuwait
      • 6.7.4.1. Market estimates and forecast, 2018 - 2030 (Revenue, USD Million)

Chapter 7. Competitive Landscape

  • 7.1. Recent Developments & Impact Analysis, By Key Market Participants
  • 7.2. Market Participant Categorization
    • 7.2.1. Acacia Pharma
      • 7.2.1.1. Company overview
      • 7.2.1.2. Financial performance
      • 7.2.1.3. Type benchmarking
      • 7.2.1.4. Strategic initiatives
    • 7.2.2. Parnell Pharmaceuticals, Inc.
      • 7.2.2.1. Company overview
      • 7.2.2.2. Financial performance
      • 7.2.2.3. Type benchmarking
      • 7.2.2.4. Strategic initiatives
    • 7.2.3. Pfizer, Inc.
      • 7.2.3.1. Company overview
      • 7.2.3.2. Financial performance
      • 7.2.3.3. Type benchmarking
      • 7.2.3.4. Strategic initiatives
    • 7.2.4. GlaxoSmithKline plc
      • 7.2.4.1. Company overview
      • 7.2.4.2. Financial performance
      • 7.2.4.3. Type benchmarking
      • 7.2.4.4. Strategic initiatives
    • 7.2.5. Church & Dwight Co., Inc.
      • 7.2.5.1. Company overview
      • 7.2.5.2. Financial performance
      • 7.2.5.3. Type benchmarking
      • 7.2.5.4. Strategic initiatives
    • 7.2.6. Lupin
      • 7.2.6.1. Company overview
      • 7.2.6.2. Financial performance
      • 7.2.6.3. Type benchmarking
      • 7.2.6.4. Strategic initiatives
    • 7.2.7. Sun Pharmaceutical Industries, Ltd.
      • 7.2.7.1. Company overview
      • 7.2.7.2. Financial performance
      • 7.2.7.3. Type benchmarking
      • 7.2.7.4. Strategic initiatives
    • 7.2.8. Hikma Pharmaceuticals PLC
      • 7.2.8.1. Company overview
      • 7.2.8.2. Financial performance
      • 7.2.8.3. Type benchmarking
      • 7.2.8.4. Strategic initiatives
    • 7.2.9. Pendopharm
      • 7.2.9.1. Company overview
      • 7.2.9.2. Financial performance
      • 7.2.9.3. Type benchmarking
      • 7.2.9.4. Strategic initiatives
    • 7.2.10. OraCoat
      • 7.2.10.1. Company overview
      • 7.2.10.2. Financial performance
      • 7.2.10.3. Type benchmarking
      • 7.2.10.4. Strategic initiatives

List of Tables

  • Table 1 List of Abbreviations
  • Table 2 North America xerostomia therapeutics market, by type, 2018 - 2030 (USD Million)
  • Table 3 North America xerostomia therapeutics market, by product, 2018 - 2030 (USD Million)
  • Table 4 North America xerostomia therapeutics market, by region, 2018 - 2030 (USD Million)
  • Table 5 U.S. xerostomia therapeutics market, by type, 2018 - 2030 (USD Million)
  • Table 6 U.S. xerostomia therapeutics market, by product, 2018 - 2030 (USD Million)
  • Table 7 Canada xerostomia therapeutics market, by type, 2018 - 2030 (USD Million)
  • Table 8 Canada xerostomia therapeutics market, by product, 2018 - 2030 (USD Million)
  • Table 9 Europe xerostomia therapeutics market, by type, 2018 - 2030 (USD Million)
  • Table 10 Europe xerostomia therapeutics market, by product, 2018 - 2030 (USD Million)
  • Table 11 Europe xerostomia therapeutics market, by region, 2018 - 2030 (USD Million)
  • Table 12 Germany xerostomia therapeutics market, by type, 2018 - 2030 (USD Million)
  • Table 13 Germany xerostomia therapeutics market, by product, 2018 - 2030 (USD Million)
  • Table 14 UK xerostomia therapeutics market, by type, 2018 - 2030 (USD Million)
  • Table 15 UK xerostomia therapeutics market, by product, 2018 - 2030 (USD Million)
  • Table 16 France xerostomia therapeutics market, by type, 2018 - 2030 (USD Million)
  • Table 17 France xerostomia therapeutics market, by product, 2018 - 2030 (USD Million)
  • Table 18 Italy xerostomia therapeutics market, by type, 2018 - 2030 (USD Million)
  • Table 19 Italy xerostomia therapeutics market, by product, 2018 - 2030 (USD Million)
  • Table 20 Spain xerostomia therapeutics market, by type, 2018 - 2030 (USD Million)
  • Table 21 Spain xerostomia therapeutics market, by product, 2018 - 2030 (USD Million)
  • Table 22 Sweden xerostomia therapeutics market, by type, 2018 - 2030 (USD Million)
  • Table 23 Sweden xerostomia therapeutics market, by product, 2018 - 2030 (USD Million)
  • Table 24 Norway xerostomia therapeutics market, by type, 2018 - 2030 (USD Million)
  • Table 25 Norway xerostomia therapeutics market, by product, 2018 - 2030 (USD Million)
  • Table 26 Denmark xerostomia therapeutics market, by type, 2018 - 2030 (USD Million)
  • Table 27 Denmark xerostomia therapeutics market, by product, 2018 - 2030 (USD Million)
  • Table 28 APAC xerostomia therapeutics market, by type, 2018 - 2030 (USD Million)
  • Table 29 APAC xerostomia therapeutics market, by product, 2018 - 2030 (USD Million)
  • Table 30 APAC xerostomia therapeutics market, by region, 2018 - 2030 (USD Million)
  • Table 31 Japan xerostomia therapeutics market, by type, 2018 - 2030 (USD Million)
  • Table 32 Japan xerostomia therapeutics market, by product, 2018 - 2030 (USD Million)
  • Table 33 China xerostomia therapeutics market, by type, 2018 - 2030 (USD Million)
  • Table 34 China xerostomia therapeutics market, by product, 2018 - 2030 (USD Million)
  • Table 35 India xerostomia therapeutics market, by type, 2018 - 2030 (USD Million)
  • Table 36 India xerostomia therapeutics market, by product, 2018 - 2030 (USD Million)
  • Table 37 Australia xerostomia therapeutics market, by type, 2018 - 2030 (USD Million)
  • Table 38 Australia xerostomia therapeutics market, by product, 2018 - 2030 (USD Million)
  • Table 39 Thailand xerostomia therapeutics market, by type, 2018 - 2030 (USD Million)
  • Table 40 Thailand xerostomia therapeutics market, by product, 2018 - 2030 (USD Million)
  • Table 41 South Korea xerostomia therapeutics market, by type, 2018 - 2030 (USD Million)
  • Table 42 South Korea xerostomia therapeutics market, by product, 2018 - 2030 (USD Million)
  • Table 43 Latin America xerostomia therapeutics market, by type, 2018 - 2030 (USD Million)
  • Table 44 Latin America xerostomia therapeutics market, by product, 2018 - 2030 (USD Million)
  • Table 45 Latin America xerostomia therapeutics market, by region, 2018 - 2030 (USD Million)
  • Table 46 Brazil xerostomia therapeutics market, by type, 2018 - 2030 (USD Million)
  • Table 47 Brazil xerostomia therapeutics market, by product, 2018 - 2030 (USD Million)
  • Table 48 Mexico xerostomia therapeutics market, by type, 2018 - 2030 (USD Million)
  • Table 49 Mexico xerostomia therapeutics market, by product, 2018 - 2030 (USD Million)
  • Table 50 Argentina xerostomia therapeutics market, by type, 2018 - 2030 (USD Million)
  • Table 51 Argentina xerostomia therapeutics market, by product, 2018 - 2030 (USD Million)
  • Table 52 Middle East and Africa xerostomia therapeutics market, by type, 2018 - 2030 (USD Million)
  • Table 53 Middle East and Africa xerostomia therapeutics market, by product, 2018 - 2030 (USD Million)
  • Table 54 Middle East and Africa xerostomia therapeutics market, by region, 2018 - 2030 (USD Million)
  • Table 55 South Africa xerostomia therapeutics market, by type, 2018 - 2030 (USD Million)
  • Table 56 South Africa xerostomia therapeutics market, by product, 2018 - 2030 (USD Million)
  • Table 57 Saudi Arabia xerostomia therapeutics market, by type, 2018 - 2030 (USD Million)
  • Table 58 Saudi Arabia xerostomia therapeutics market, by product, 2018 - 2030 (USD Million)
  • Table 59 UAE xerostomia therapeutics market, by type, 2018 - 2030 (USD Million)
  • Table 60 UAE xerostomia therapeutics market, by product, 2018 - 2030 (USD Million)
  • Table 61 Kuwait xerostomia therapeutics market, by type, 2018 - 2030 (USD Million)
  • Table 62 Kuwait xerostomia therapeutics market, by product, 2018 - 2030 (USD Million)

List of Figure

Fig. 1 Market research process

Fig. 2 Data triangulation techniques

Fig. 3 Primary research pattern

Fig. 4 Market research approaches

Fig. 5 Value-chain-based sizing & forecasting

Fig. 6 QFD modeling for market share assessment

Fig. 7 Market formulation & validation

Fig. 8 Xerostomia therapeutics: market outlook

Fig. 9 Xerostomia therapeutics competitive insights

Fig. 10 Parent market outlook

Fig. 11 Related/ancillary market outlook

Fig. 12 Penetration and growth prospect mapping

Fig. 13 Industry value chain analysis

Fig. 14 Xerostomia therapeutics market driver impact

Fig. 15 Xerostomia therapeutics market restraint impact

Fig. 16 Xerostomia therapeutics market strategic initiatives analysis

Fig. 17 Xerostomia therapeutics market: type movement analysis

Fig. 18 Xerostomia therapeutics market: type outlook and key takeaways

Fig. 19 Over-the-counter (OTC) market estimates and forecast, 2018 - 2030 (USD Million)

Fig. 20 Prescription market estimates and forecast, 2018 - 2030 (USD Million)

Fig. 21 Xerostomia therapeutics market: product movement analysis

Fig. 22 Xerostomia therapeutics market: product outlook and key takeaways

Fig. 23 Salivary stimulants market estimates and forecast, 2018 - 2030 (USD Million)

Fig. 24 Salivary substitutes market estimates and forecast, 2018 - 2030 (USD Million)

Fig. 25 Dentifrices market estimates and forecast, 2018 - 2030 (USD Million)

Fig. 26 Xerostomia therapeutics market: material movement analysis

Fig. 27 Global xerostomia therapeutics market: regional movement analysis

Fig. 28 Global xerostomia therapeutics market: regional outlook and key takeaways

Fig. 29 North America, by country

Fig. 30 North America market estimates and forecast, 2018 - 2030 (USD Million)

Fig. 31 U.S. market estimates and forecast, 2018 - 2030 (USD Million)

Fig. 32 Canada market estimates and forecast, 2018 - 2030 (USD Million)

Fig. 33 Europe. market estimates and forecast, 2018 - 2030 (USD Million)

Fig. 34 UK market estimates and forecast, 2018 - 2030 (USD Million)

Fig. 35 Germany market estimates and forecast, 2018 - 2030 (USD Million)

Fig. 36 France market estimates and forecast, 2018 - 2030 (USD Million)

Fig. 37 Italy market estimates and forecast, 2018 - 2030 (USD Million)

Fig. 38 Spain market estimates and forecast, 2018 - 2030 (USD Million)

Fig. 39 Sweden market estimates and forecast, 2018 - 2030 (USD Million)

Fig. 40 Norway market estimates and forecast, 2018 - 2030 (USD Million)

Fig. 41 Denmark market estimates and forecast, 2018 - 2030 (USD Million)

Fig. 42 Asia Pacific market estimates and forecast, 2018 - 2030 (USD Million)

Fig. 43 China market estimates and forecast, 2018 - 2030 (USD Million)

Fig. 44 Japan market estimates and forecast, 2018 - 2030 (USD Million)

Fig. 45 India market estimates and forecast, 2018 - 2030 (USD Million)

Fig. 46 Australia market estimates and forecast, 2018 - 2030 (USD Million)

Fig. 47 Thailand market estimates and forecast, 2018 - 2030 (USD Million)

Fig. 48 South Korea market estimates and forecast, 2018 - 2030 (USD Million)

Fig. 49 Latin America market estimates and forecast, 2018 - 2030 (USD Million)

Fig. 50 Brazil market estimates and forecast, 2018 - 2030 (USD Million)

Fig. 51 Mexico market estimates and forecast, 2018 - 2030 (USD Million)

Fig. 52 Argentina market estimates and forecast, 2018 - 2030 (USD Million)

Fig. 53 Middle East and Africa. market estimates and forecast, 2018 - 2030 (USD Million)

Fig. 54 Saudi Arabia market estimates and forecast, 2018 - 2030 (USD Million)

Fig. 55 South Africa market estimates and forecast, 2018 - 2030 (USD Million)

Fig. 56 UAE market estimates and forecast, 2018 - 2030 (USD Million)

Fig. 57 Kuwait market estimates and forecast, 2018 - 2030 (USD Million)